Antinori Andrea, Di Biagio Antonio, Marcotullio Simone, Andreoni Massimo, Chirianni Antonio, d'Arminio Monforte Antonella, Galli Massimo, Mazzotta Francesco, Mussini Cristina, Puoti Massimo, Lazzarin Adriano
National Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, Italy.
IRCCS AOU San Martino Hospital, Genova, Italy.
New Microbiol. 2017 Apr;40(2):86-98.
The Italian Society of Infectious and Tropical Diseases (SIMIT) of the Technical Health Committee, Ministry of Health (Sections L and M) of Italy have supported recommendations for the Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. This publication summarizes the latest updates to the 2016 version of the Italian Guidelines for the management of HIV-1 infected patients and the use of antiretroviral drugs. In particular, new recommendations were released concerning the following topics: estimate of the HIV continuum of care in Italy, optimal timing and preferred drug combinations for starting antiretroviral therapy, treatment optimization, and pre-exposure prophilaxis (PrEP). For a complete review of clinical and therapeutic relevant topics we refer the reader to the extended version of the Guidelines.
意大利卫生部技术卫生委员会（第L和M部门）的意大利传染病和热带病学会（SIMIT）支持有关意大利抗逆转录病毒药物使用指南以及HIV-1感染者诊断临床管理的建议。本出版物总结了2016年版意大利HIV-1感染患者管理及抗逆转录病毒药物使用指南的最新更新内容。特别是，发布了关于以下主题的新建议：意大利HIV连续护理评估、开始抗逆转录病毒治疗的最佳时机和首选药物组合、治疗优化以及暴露前预防（PrEP）。有关临床和治疗相关主题的完整综述，我们请读者参考指南的扩展版本。
